All companies
ResMed logo
HealthcareRMD

ResMed (RMD) Financial Forecast Calculator

Interactive 5-year forecast and DCF for ResMed. Adjust revenue growth, gross margin, capex intensity, WACC, and terminal growth - see revenue, free cash flow, and enterprise value update in real time. Seeded from ResMed’s most recent SEC filings.

Revenue FY30
$7.72B
from $4.22B
FCF FY30
$1.47B
Margin 19.0%
Enterprise value
$19.65B
4.7× LTM revenue
Equity value
$19.17B
Net debt $478.8M
Revenue & free cash flow - history and 5-year forecast
Line (area)
Bars
Historicals from SEC EDGAR (grey). Forecast years (color) update live as you move the sliders.

Assumptions

Revenue growth (annual)
12.8%
-10.0%baseline 12.8%40.0%
Gross margin
57.1%
5.0%baseline 57.1%90.0%
Capex % of revenue
3.1%
0.0%baseline 3.1%30.0%
WACC (discount rate)
9.00%
4.0%baseline 9.0%18.0%
Terminal growth
2.50%
0.0%baseline 2.5%5.0%

Need this as an Excel model?

Keep iterating on the ResMed forecast in Excel. The downloadable sample has every assumption you see here plus a fully integrated income statement, balance sheet, cash flow, and debt schedule - five years of SEC historicals and live formulas in a fully editable workbook.

income_statement.xlsx
Income statement, brown brand palette
income_statement.xlsx
Income statement, green brand palette
income_statement.xlsx
Income statement, red brand palette

Frequently asked

What is ResMed's primary business focus and what products do they offer?+

ResMed is a global leader in digital health and cloud-connected medical devices, primarily focused on diagnosing and treating sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. The company provides hardware such as CPAP machines and masks, alongside a growing portfolio of out-of-hospital software solutions.

How does ResMed generate revenue, and what are its key business segments?+

ResMed generates revenue through a blend of hardware sales, highly recurring consumable revenue from mask resupply, and high-margin subscription revenue from its SaaS platforms. Its main business segments are Sleep and Breathing Health, which accounts for approximately 88% of revenue, and Residential Care Software, making up about 12% of revenue.

What is the assumed revenue growth rate for ResMed in the financial model?+

The financial model for ResMed assumes a revenue growth rate of approximately 12.8%. This assumption is a key input for forecasting the company's top-line performance over the forecast horizon from FY2026 to FY2030.

What are the key elements considered in the equity valuation for ResMed?+

The equity valuation for ResMed focuses on several key elements, including device volume growth, the recurring revenue from mask resupply, and the expansion of its SaaS platforms. The gross margin trajectory is also a critical factor in understanding the company's profitability and overall valuation.

Can I download an Excel financial model for ResMed, and what is its forecast horizon?+

Yes, an Excel financial model for ResMed is available for download. This comprehensive model provides an equity valuation and scenario planning tool with a forecast horizon spanning from fiscal year 2026 to fiscal year 2030.

What is the assumed capital expenditure as a percentage of revenue in ResMed's financial model?+

In ResMed's financial model, capital expenditure is assumed to be approximately 3.1% of revenue. This figure helps project the company's investment in assets like advanced manufacturing facilities and distribution centers, balancing maintenance and growth capex.

Have more financial modelling questions? Contact us

Go further

Build the financial model you need with Fina

Browse templates, examples, and downloadable Excel models for the analysis you are trying to build. If you can't find your model, ask Fina to build a model for your specific needs.

Start for free
Excel financial model spreadsheet preview showing Customer Rollforward
Fina interactive chat interface preview